CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +30.1% | +34.1% | +92.2% | +23.7% | +67.0% | -13.0% | |
| – | +275.4% | +258.6% | +219.9% | +107.8% | -7.7% | -14.8% | +66.4% | -74.6% | +106.5% | +18.2% | +29.7% | +25.9% | +5.3% | -16.9% | +683.9% | +197.4% | -78.3% | +545.3% | +2,553.8% | +14.9% | +0.3% | |
| – | – | – | -54.4% | +29.0% | -16.2% | -25.2% | -7.4% | -18.4% | -48.3% | +342.4% | +103.8% | +15.8% | +31.1% | +47.5% | +7.7% | +63.7% | -3.0% | +30.2% | +80.2% | +56.1% | +11.4% | |
| – | – | – | – | – | – | – | – | -53.8% | +507.6% | -14.2% | -14.2% | -37.5% | +173.2% | +36.8% | +7.7% | -777.9% | – | -16.5% | – | – | – | |
| – | +1,147.4% | +84.9% | -363.7% | – | -169.0% | – | – | -145.5% | – | +304.2% | -13.8% | -233.4% | – | +132.1% | -123.3% | – | – | +173.4% | -371.9% | – | -297.0% | |
| – | +115.2% | +434.3% | +212.9% | -98.0% | +70.9% | +24.8% | +26.3% | +1,347.0% | -82.0% | +507.8% | -59.1% | +309.4% | -4.2% | +0.0% | -78.9% | -41.2% | +8,860.9% | -97.2% | +281,775.9% | -99.3% | -89.6% | |
| – | +115.2% | +434.3% | +212.9% | -98.0% | +70.9% | +24.8% | +26.3% | +388,288.1% | -46.7% | +16.6% | -99.9% | – | -100.1% | +392,169.1% | – | -113.5% | +119.9% | – | -3,287.1% | -99.8% | -89.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +72.9% | +89.7% | +57.1% | +30.1% | -100.0% | – | -100.0% | – | -105.0% | +21,487.5% | -42.9% | -85.8% | -69.9% | +8,447.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,893.6% | – | – | -9.5% | -60.6% | +280.6% | +163.1% | +24.7% | +57.1% | +30.1% | -99.8% | +83,033.1% | -99.5% | +280.8% | -37.1% | -1,260.1% | – | -740.9% | – | -112.1% | |
| – | – | +3,248.6% | -122.8% | – | – | – | – | -933.9% | – | +753.7% | +178.1% | -174.9% | – | -193.9% | – | -44.2% | +1.2% | +208.1% | -226.6% | – | -49.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +30.2% | +31.8% | +95.5% | -46.7% | +286.8% | -12.8% |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.